Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 259

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 259
---

U.S. dollars in thousands, except share and per share data

| NOTE 8:- | SUBSEQUENT EVENTS |

The Company evaluated subsequent events
through January 24, 2025, the date these unaudited interim financial statements were available to be issued. The Company concluded
that no subsequent events have occurred that would require recognition or disclosure in the financial statements, except:

In October 2024, the Company signed an addendum to the 2020 CLA agreement
(the “October 2024 Addendum”) pursuant to which certain lenders (the “Participating Lenders”) under the 2020 CLAs
will increase their CLA and up to an additional aggregate amount of $450. According to the October 2024 Addendum, the 2020 CLAs of the
non-participating Lenders shall bear interest at 8% per annum until maturity commencing as of July 1, 2024, and of the 2020 CLA of the
participating Lenders commencing as of March 31, 2025. In addition, pursuant the October 2024 Addendum, upon the earlier of March 31,
2025 or occurrence of an IPO, the CLA 2020 principal and accrued interest will be automatically converted into 243,955 ordinary shares
based on a pre money valuation of $5,150. In addition, the Company will pay to the Participating Lender an amount of $340 as a risk premium,
which will be automatically converted in the same terms as above into 221,456 Ordinary Shares of the Company. As of January 24, 2025,
the Company received $450 out of the $450 proceeds.

Between October 2024 and November 2024, the Company entered into the
October 2024 bridge loan agreements (the “Bridge Loans”), pursuant to which the Company obtained a bridge loan from the lenders
thereto including certain related parties (the “Bridge Loan Lenders”). The Bridge Loans will be repaid at the earlier of consummation
of an IPO or on March 31, 2025 (the “Bridge Loans Maturity Date”) and shall bear interest at 8% per annum until maturity commencing
as of September 1, 2024. In addition, at the Bridge Loans Maturity Date, the Company shall pay the Bridge Loan Lenders, on a pro rata
basis to each Bridge Loan Lender participation to the loan amount, an aggregate